Business
Bioasis Announces Filing of Quarterly Financial Statements and MD&A
Bioasis Announces Filing of Quarterly Financial Statements and MD&A.
About this update from Bioasis Technologies Inc.
[{"type":"text","content":"\n \n BIOASIS \n TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a biopharmaceutical \n company focused on the delivery of therapeutics across the blood-brain \n barrier (BBB) and into the central nervous system for the treatment of \n neurological diseases and disorders, today announced that it has filed \n its unaudited quarterly financial statements and management's discussion \n and analysis for the period ended Nov. 30, 2017. Both are available \n under the Company's profile on SEDAR at www.sedar.com \n and on the Company's website at www.bioasis.us.\n \n \n On behalf of the Board of Directors of Bioasis Technologies Inc.\n \n \n Mark Day, Ph.D., President and Chief Executive Officer\n \n \n About BioasisBioasis Technologies, Inc. is a preclinical \n biopharmaceutical company focused on the delivery of therapeutics across \n the blood-brain barrier (BBB) and into the central nervous system for \n the treatment of neurological diseases and disorders. The delivery of \n therapeutics across the BBB represents the single greatest challenge in \n treating neurological disorders. The company is developing and \n commercializing the xB3 platform, Bioasis’ proprietary \n blood-brain barrier delivery technology, to address unmet medical needs \n in the treatment of central nervous system diseases and disorders. The \n company maintains headquarters in Vancouver, Canada with offices in \n Guilford, Conn., United States. Bioasis trades on the OTCQB under the \n symbol “BIOAF” and on the TSX Venture Exchange under the symbol “BTI.” \n For more information about the company please visit www.bioasis.ca \n or www.bioasis.us.\n \n \n Forward Looking StatementsCertain statements in this \n press release contain forward-looking statements within the meaning of \n the Private Securities Litigation Reform Act of 1995 or forward-looking \n information under applicable Canadian securities legislation that may \n not be based on historical fact, including without limitation statements \n containing the words “believe”, “may”, “plan”, “will”, “estimate”, \n “continue”, “anticipate”, “intend”, “expect” and similar expressions. \n Such forward-looking statements or information involve known an...